NCT05946486: Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity.
- State
- Not started
- Phase
- Phase 3
- People
- 174 planned
- Started
- 15 Oct 2023
- Primary completion
- 15 Jan 2026
- Arms
- experimental group
- Results
- None posted
- 14 Jul 2023: Trial registered